Back to Search
Start Over
Pediatric fatty liver disease: role of ethnicity and genetics
- Publication Year :
- 2014
-
Abstract
- Non-alcoholic fatty liver disease (NAFLD) comprehends a wide range of conditions, encompassing from fatty liver or steatohepatitis with or without fibrosis, to cirrhosis and its complications. NAFLD has become the most common form of liver disease in childhood as its prevalence has more than doubled over the past 20 years, paralleling the increased prevalence of childhood obesity. It currently affects between 3% and 11% of the pediatric population reaching the rate of 46% among overweight and obese children and adolescents. The prevalence of hepatic steatosis varies among different ethnic groups. The ethnic group with the highest prevalence is the Hispanic one followed by the Caucasian and the African-American. This evidence suggests that there is a strong genetic background in the predisposition to fatty liver. In fact, since 2008 several common gene variants have been implicated in the pathogenesis of fatty liver disease. The most important is probably the patatin like phospholipase containing domain 3 gene (PNPLA3) discovered by the Hobbs' group in 2008. This article reviews the current knowledge regarding the role of ethnicity and genetics in pathogenesis of pediatric fatty liver. © 2014 Baishideng Publishing Group Inc. All rights reserved.
- Subjects :
- Genetic Markers
Cirrhosis
Adolescent
Ethnic Group
Apolipoprotein C3 gene
Farnesyl-diphosphate farnesyltransferase 1
Disease
Overweight
Childhood obesity
Liver disease
Patatin like phospholipase containing domain 3 gene
Risk Factors
Genetic Marker
medicine
Ethnicity
Non alcoholic fatty liver disease
Prevalence
Humans
Genetic Predisposition to Disease
Topic Highlight
Obesity
Age of Onset
Child
Membrane Protein
Adaptor Proteins, Signal Transducing
Genetics
Apolipoprotein C-III
business.industry
Fatty liver
Gastroenterology
Membrane Proteins
Insulin resistance
General Medicine
Lipase
medicine.disease
Pedigree
Fatty Liver
Farnesyl-Diphosphate Farnesyltransferase
Phenotype
Glucokinase regulatory protein
Steatosis
Steatohepatitis
medicine.symptom
business
Human
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....641d522de254ed8e1cfd15365a1d29e9